|Bid||198.87 x 800|
|Ask||198.89 x 1100|
|Day's Range||198.64 - 199.53|
|52 Week Range||149.69 - 199.95|
|PE Ratio (TTM)||18.75|
|Earnings Date||Oct 29, 2018 - Nov 2, 2018|
|Forward Dividend & Yield||2.00 (1.01%)|
|1y Target Est||203.00|
This could indicate that investors who seek to profit from falling equity prices are not currently targeting AET. Over the last month, growth of ETFs holding AET is favorable, with net inflows of $12.63 billion.
Now that AET has finally reached our target area a fresh look is certainly warranted and perhaps overdue. In this daily bar chart of AET, below, we can see that prices have been in an uptrend the past 12 months. The daily On-Balance-Volume (OBV) line has been moving up with the price action from early April.
Aetna has introduced the regional Aetna Whole Health - Southern California plan to employers with employees in San Diego County, Orange County, Los Angeles County and select portions of the Inland Empire.
The U.S. Department of Justice may not have plans to challenge the $69 billion mega-merger of CVS and Aetna. Dr. Theresa Rohr-Kirchgraber said the deal could severely limit patient choice when it comes to seeing a doctor or filling a prescription, and will almost certainly increase health-care costs by providing even less transparency into the already murky world of prescription drug prices. While the U.S. Department of Justice may not have plans to challenge the $69 billion mega-merger of CVS CVS and Aetna AET , patients and physicians should do so at every turn.
The pharmacy services giant reported strong prescription volume growth in the second quarter but a big writedown for its struggling LTC business.
The American Medical Association, which represents U.S. physicians, urged the U.S. Justice Department on Wednesday to stop CVS Health Corp's plan to buy insurance provider Aetna Inc, saying the deal could result in higher prices for prescription medicines. The AMA said that the $69 billion deal, announced in December, would lead to a "substantial reduction" of competition in pharmacy benefit (PBM) services market and the Medicare Part D prescription drug plan for seniors. The AMA said the deal would increase concentration in 10 of the 34 Medicare Part D regional markets to the point where it is presumed likely to increase market power.
Musk Pulls Nuclear Option on Tesla Shorts In quite a clever move that amounts to a surprise squeeze on Tesla (NASDAQ:TSLA) shorts, the notorious and constantly-in-the-news for one thing or another Tesla CEO Elon Musk proposed taking Tesla private yesterday, which rocketed shares higher 11%. The deal he proposed and says that he has somehow […] The post Market Morning: Musk Nukes Tesla Shorts, Negatively Priced Power, Samsung All In on AI appeared first on Market Exclusive.
CVS Health Corp. has dodged one hurdle in its bid to buy insurer Aetna Inc., as antitrust enforcers don’t see competitive problems that can stem from uniting companies that operate at different levels of a supply chain, according to two people familiar with the matter. The investigation by the Justice Department’s antitrust division hasn’t turned up vertical- competition concerns from the merger, according to the people, who declined to be identified because the review is confidential. CVS’s $68 billion deal to buy Aetna was announced on the heels of the Justice Department’s unsuccessful lawsuit to block AT&T Inc.’s takeover of Time Warner Inc., a vertical deal that combined a pay-TV distributor with a programmer.
NYU School of Medicine announces plans to offer full scholarships to all students, covering a yearly tuition of $55,018. Yahoo Finance's Seana Smith, Pras Subramanian, Andy Serwer and Dan Howley discuss.